ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,524.40
      1.06%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      -2.20%
      Bitcoin
      67,896.66
      3.20%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Coeptis Therapeutics Holdings Inc (COEP)

      7. Coeptis Therapeutics Holdings Inc (COEP) Financials

      Coeptis Therapeutics Holdings Inc

      Coeptis Therapeutics Holdings Inc (COEP)

      NASDAQ
      0.2601
      -0.0075
      (-2.80%)
      At close: July 26 4:00PM
      Delayed by 15 minutes
      0.2626
      0.0025
      ( 0.96% )
      After Hours: 6:41PM
      Delayed by 15 minutes

      Coeptis Therapeutics Holdings Inc Financial Summary

      The current COEP market cap is 9.75M. The company's latest EPS is USD -0.5729 and P/E is -20.86.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -6.45M-3.6M-7.81M-3.63M-2.92M
      Net Income -7.87M-3.11M-6.26M-4.03M-3M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -2k-68k-681k-34.2M-21.49M
      Net Income -2k-67k15.23M-37.57M-21.27M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 5.94M7.16M7.17M8.07M9.39M
      Total Liabilities 4.66M4.67M2.16M3.76M5.04M
      Total Equity 1.29M2.49M5.01M4.31M4.36M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 172k76.71M76.17M7.92M8.07M
      Total Liabilities 156k2.26M7.19M3.11M3.76M
      Total Equity 16k5M-6.77M4.8M4.31M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -1.68M-3.59M-5.55M-7.24M-1.9M
      Investing N/A -350k N/A N/A -100k
      Financing N/A 3.39M3.17M4.92M1.56M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -2k-116k-503k-3.88M-7.24M
      Investing N/A -75.75M N/A N/A N/A
      Financing 2k76.77M N/A 5.49M4.92M

      Stats and Ratios

      Market Cap 9.75M
      Price to Earnings Ratio -20.86
      Price to Sales Ratio 0
      Price to Cash Ratio 301.77
      Price to Book Ratio 102.82
      Dividend Yield -

      Share Statistics

      Shares Outstanding 37.12M
      Average Volume (1 week) 64.87k
      Average Volume (1 Month) 80.76k
      52 Week Change -77.17%
      52 Week High 1.38
      52 Week Low 0.2303
      Spread (Intraday) 0.03 (12.3%)

      Company Info

      Company Name Coeptis Therapeutics Holdings Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.coeptistx.com
      Industry biological pds,ex diagnstics (2836)